Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier

Brain Res. 2003 Apr 4;968(1):69-79. doi: 10.1016/s0006-8993(02)04271-3.

Abstract

The transport of L-carnitine (4-N-trimethylamino-3-hydroxybutyric acid), a compound known to be transported by the organic cation transporter/carnitine transporter OCTN2, was studied in immortalized rat brain endothelial cells (RBE4). The cells were found to take up L-carnitine by a sodium-dependent process. This uptake process was saturable with an apparent Michaelis-Menten constant for L-carnitine of 54+/-10 microM and a maximal velocity of 215+/-35 pmol/mg protein/h. Besides L-carnitine, the cells also took up acetyl-L-carnitine and propionyl-L-carnitine in a sodium-dependent manner and TEA in a sodium-independent manner. RT-PCR with primers specific for the rat OCTN2 transporter revealed the existence of OCTN2 mRNA in RBE4 cells. Screening of a cDNA library from RBE4 cells with rat OCTN2 cDNA as a probe identified a positive clone which showed, when expressed in HeLa cells, the functional characteristics of OCTN2. The HeLa cells expressing the RBE4 OCTN2 cDNA showed a sixfold increase in L-carnitine uptake and a fourfold increase in TEA uptake in a sodium-containing buffer. Typical inhibitors for organic cation transporters (e.g. MPP(+) or TEA) showed an inhibitory effect on the transport of L-carnitine and TEA into the transfected cells. Similarly, unlabeled L-carnitine inhibited the transport of [3H]-L-carnitine and [14C]TEA in transfected HeLa cells. It is concluded that RBE4 cells, a widely used in vitro model of the blood-brain barrier (BBB), express the organic cation/carnitine transporter OCTN2.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-4-phenylpyridinium / pharmacokinetics
  • Animals
  • Biological Transport / physiology
  • Blood-Brain Barrier / physiology*
  • Carnitine / analogs & derivatives
  • Carnitine / pharmacokinetics
  • Carrier Proteins / genetics*
  • Carrier Proteins / physiology
  • Cell Line
  • Choline / pharmacokinetics
  • Cloning, Molecular
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Endothelium, Vascular
  • HeLa Cells / metabolism
  • Humans
  • In Vitro Techniques
  • Kidney / metabolism
  • Kinetics
  • Membrane Proteins / genetics*
  • Membrane Proteins / physiology
  • Models, Biological
  • Organic Cation Transport Proteins*
  • RNA, Messenger / biosynthesis
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Solute Carrier Family 22 Member 5
  • Tetraethylammonium / pharmacokinetics
  • Time Factors
  • Tissue Distribution
  • Transcription, Genetic
  • Transfection
  • Tritium / pharmacokinetics

Substances

  • Carrier Proteins
  • Membrane Proteins
  • Organic Cation Transport Proteins
  • RNA, Messenger
  • SLC22A5 protein, human
  • Solute Carrier Family 22 Member 5
  • Tritium
  • Tetraethylammonium
  • Choline
  • 1-Methyl-4-phenylpyridinium
  • Carnitine